Sandu Pharmaceuticals Ltd — Others, 28-05-2025: Corp Action

Sandu Pharmaceuticals has announced a board meeting and recommended a dividend of Rs. 0.80 per equity share (8% on face value of Rs. 10) for the financial year ended March 31, 2025. The dividend is subject to shareholder approval at the upcoming Annual General Meeting. Details on the record date and dividend payout will be shared later. This dividend indicates the company’s steady cash return approach, reflecting confidence in its earnings stability and providing income to shareholders.